Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C. Owen(The University of Sydney), Xue Bai(Peking University Cancer Hospital), Gaik Tin Quah(Blacktown & Mount Druitt Hospital), Serigne Lo(Melanoma Institute Australia), Clara Allayous(Université Paris Cité), Sophia Callaghan(The Christie NHS Foundation Trust), Clara Martínez-Vila(Hospital Clínic de Barcelona), Roslyn Wallace(The University of Melbourne), Prachi Bhave(The Alfred Hospital), Irene L. M. Reijers(The Netherlands Cancer Institute), Nicola Thompson(Cambridge University Hospitals NHS Foundation Trust), Vito Vanella(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Camille L. Gérard(University of Lausanne), Sandrine Aspeslagh, Alice Labianca(Ospedale Papa Giovanni XXIII), Adnan Khattak(Fiona Stanley Hospital), Mario Mandalà(University of Perugia), Wen Xu(Princess Alexandra Hospital), Bart Neyns, Olivier Michielin(University of Lausanne), Christian U. Blank(The Netherlands Cancer Institute), Sarah J. Welsh(Cambridge University Hospitals NHS Foundation Trust), Andrew Haydon(The Alfred Hospital), Shahneen Sandhu(The University of Melbourne), Joanna Mangana(University Hospital of Zurich), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Lisa Zimmer(University of Duisburg-Essen), Douglas B. Johnson(Vanderbilt University Medical Center), Ana Arance(Hospital Clínic de Barcelona), Paul Lorigan(The Christie NHS Foundation Trust), Célèste Lebbé(Inserm), Matteo S. Carlino(Blacktown & Mount Druitt Hospital), Ryan J. Sullivan(Massachusetts General Hospital), Georgina V. Long(Royal North Shore Hospital), Alexander M. Menzies(Melanoma Institute Australia)
Cited by 183Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis